Center for Global Development’s Post

A new era for CGD! We are thrilled to announce Dr. Rachel Glennerster as the new President of CGD! Rachel's pioneering work has shaped markets to promote innovation in addressing global challenges, including pandemics and climate change.  Renowned for her rigorous approach to development economics, she has leveraged randomized trials to address critical issues spanning democracy, health, education, and women's empowerment.  Rachel is ready to build on the legacies of Nancy Birdsall and Masood Ahmed, to propel CGD forward with innovative ideas and new approaches—at a time when the world needs them more than ever. Read more >> https://lnkd.in/g5JbN-kc

Within the #EU, $15 billion a year is spent on treating drug resistant infections. Building on momentum from #UNGA, Katherine Klemperer, Javier Guzman, and Anthony McDonnell offer an idea for how the new EU commission can take a global leadership role in tackling AMR: https://bit.ly/4gIw7Qp

On October 10, join USAID and the Center for Global Development for expert-led conversations on the power of cost-effectiveness to identify and scale effective programs. During the event, the Agency will launch its first-ever position papers on cost-effectiveness and on direct monetary transfers. USAID Deputy Administrator for Policy and Programming Isobel Coleman will deliver a keynote address highlighting the importance of cost-effectiveness to improve lives and communities. RSVP to join us! ⬇ https://bit.ly/3XLOKKI

Mark Lowcock and Ranil Dissanayake's book, "The Rise and Fall of the Department for International Development," is out today! Their work traces DFID’s trajectory from its origins to its unravelling, distilling timely lessons for government aid institutions in the UK and beyond. Discover more about the book ⬇ https://lnkd.in/e7znhf64

Why do low- and middle-income countries see fewer #antimicrobial registrations and product introductions than other countries? 💊 Through interviews with experts, Katherine Klemperer, Fatema Rafiqi and Anthony McDonnell dig into this rollout problem: https://bit.ly/4cTMBSw

Dive into this week's #development #newsletter. Discover insights on AMR fallout, the UN Pact for the Future, and more:

The EU’s Carbon Border Adjustment Mechanism aims to hold major emitters to account, but fails to account for the challenges of low- and middle-income countries.🇪🇺 Ian Mitchell and Beata Cichocka experts suggest the #EU reform #CBAM with longer transition periods and income going to #climate loss and damage funds ⬇🇪🇺 https://bit.ly/3zy8x86

🗨 "It harnesses the power of markets to deliver the kind of #innovation that we need." Hear CGD President Rachel Glennerster discuss the unique benefits of #market shaping at a recent CGD & University of Chicago's Market Shaping Accelerator event. Full discussions ⬇ https://bit.ly/3Z1xjYA

🌎 USAID and UNICEF have announced the Partnership for a Lead-Free Future, the first-ever global public-private partnership dedicated to fighting childhood #leadexposure in low- and middle-income countries. Rachel Bonnifield celebrates the historic launch ⬇🌟 https://bit.ly/3TK9jFZ

A new CGD report measures the potential economic burden of AMR between now and 2050.💊 The world currently spends an estimated $66 billion annually treating people with a drug resistant infection—and if resistance is allowed to increase unimpeded, the amount will rise to $159 billion in 2050. But action now can reap great economic gains. Read on to explore how improved access to and innovation of new antimicrobials can save lives and boost the economy ⬇ https://lnkd.in/eMkHcaWc